Phase 1 Trials of Anti-Enpp3 Antibody Drug Conjugates in Advanced Refractory Renal Cell Carcinomas
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0481
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2018
Authors
Publisher
American Association for Cancer Research (AACR)